ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 134 filers reported holding ANIKA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,777,000 | +23.7% | 77,137 | +20.9% | 0.00% | 0.0% |
| Q3 2016 | $3,053,000 | -11.0% | 63,801 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $3,429,000 | +27.1% | 63,907 | +5.9% | 0.00% | 0.0% |
| Q1 2016 | $2,698,000 | +19.1% | 60,339 | +1.6% | 0.00% | +33.3% |
| Q4 2015 | $2,266,000 | +20.6% | 59,388 | +0.6% | 0.00% | 0.0% |
| Q3 2015 | $1,879,000 | -4.5% | 59,036 | -0.9% | 0.00% | +50.0% |
| Q2 2015 | $1,968,000 | -5.5% | 59,590 | +17.8% | 0.00% | -33.3% |
| Q1 2015 | $2,083,000 | +2.5% | 50,596 | +1.5% | 0.00% | 0.0% |
| Q4 2014 | $2,032,000 | +10.6% | 49,869 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $1,838,000 | -17.7% | 50,135 | +4.0% | 0.00% | 0.0% |
| Q2 2014 | $2,232,000 | +27.3% | 48,186 | +13.0% | 0.00% | 0.0% |
| Q1 2014 | $1,753,000 | +8.3% | 42,647 | +0.6% | 0.00% | +50.0% |
| Q4 2013 | $1,618,000 | +82.8% | 42,410 | +14.4% | 0.00% | +100.0% |
| Q3 2013 | $885,000 | +44.1% | 37,056 | +2.6% | 0.00% | 0.0% |
| Q2 2013 | $614,000 | – | 36,126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 1,081,360 | $20,145,737 | 9.25% |
| Trigran Investments, Inc. | 2,217,019 | $41,303,065 | 4.40% |
| DIKER MANAGEMENT LLC | 50,239 | $935,953 | 0.84% |
| Virtus Investment Advisers, Inc. | 45,579 | $849,137 | 0.58% |
| Virtus Fund Advisers, LLC | 3,490 | $65,019 | 0.46% |
| CAPITAL MANAGEMENT CORP /VA | 84,225 | $1,569,112 | 0.35% |
| Riverwater Partners LLC | 17,597 | $327,832 | 0.30% |
| BOOTHBAY FUND MANAGEMENT, LLC | 617,602 | $11,505,925 | 0.27% |
| XTX Topco Ltd | 28,033 | $522,255 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 51,638 | $962 | 0.08% |